JAK Inhibitors: Are All Promises Fulfilled?
Biologic or Conventional Therapy for Early RA?
Phase 2 Study Shows Promising Results for Deucravacitinib in PsA
Baricitinib Promising for Juvenile Idiopathic Arthritis
Study Compares Intra-Articular Morphine with Steroids & Placebo in Patients with Chronic Knee Arthritis
FDA Approves Riabni, a Rituxumab Biosimilar, to Treat Patients with RA
Challenges in Reproductive Health in Rheumatic Disease
The ACR Responds to Reports of Treatment Denials in Wake of Dobbs v. Jackson Women’s Health Organization
ACR-FDA Summit Focuses on Study Design, Safety Considerations
- 1
- 2
- 3
- …
- 120
- Next Page »